MedPath

FLINDERS UNIVERSITY

FLINDERS UNIVERSITY logo
🇦🇺Australia
Ownership
Private
Established
1966-01-01
Employees
1K
Market Cap
-
Website
http://www.flinders.edu.au

Clinical Trials

188

Active:6
Completed:69

Trial Phases

5 Phases

Phase 1:6
Phase 2:11
Phase 3:13
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (172 trials with phase data)• Click on a phase to view related trials

Not Applicable
134 (77.9%)
Phase 3
13 (7.6%)
Phase 2
11 (6.4%)
Phase 4
8 (4.7%)
Phase 1
6 (3.5%)

Effects of Eszopiclone and Lemborexant in People With OSA With a Low Arousal Threshold Who Have Difficulty Sleeping

Phase 2
Not yet recruiting
Conditions
OSA - Obstructive Sleep Apnea
Interventions
First Posted Date
2025-04-15
Last Posted Date
2025-04-18
Lead Sponsor
Flinders University
Target Recruit Count
15
Registration Number
NCT06928766
Locations
🇦🇺

Flinders University, Adelaide Institute for Sleep Health, Bedford Park, South Australia, Australia

Reboxetine for Sleep Apnoea After ENT Surgery

Phase 2
Recruiting
Conditions
Sleep Apnea, Obstructive
Interventions
First Posted Date
2023-08-07
Last Posted Date
2024-10-03
Lead Sponsor
Flinders University
Target Recruit Count
20
Registration Number
NCT05978505
Locations
🇦🇺

Flinders, Private and Public Hospitals and Flinders University, Bedford Park, South Australia, Australia

BAY2586116 Nasal Spray and OSA Severity

Phase 1
Completed
Conditions
Sleep Apnea, Obstructive
Interventions
Drug: Placebo
First Posted Date
2022-09-02
Last Posted Date
2023-02-15
Lead Sponsor
Flinders University
Target Recruit Count
10
Registration Number
NCT05527457
Locations
🇦🇺

Flinders University, Bedford Park, South Australia, Australia

Assessment of Myocardial Injury in Patients Treated With Immune Checkpoint Inhibitors

Conditions
Myocarditis
Myocardial Injury
Immune Checkpoint Inhibitors
Cardiotoxicity
Interventions
Drug: Immune Checkpoint Inhibitors
First Posted Date
2022-04-27
Last Posted Date
2022-04-27
Lead Sponsor
Flinders University
Target Recruit Count
40
Registration Number
NCT05349058
Locations
🇦🇺

Flinders Medical Centre, Adelaide, South Australia, Australia

Effects of Quetiapine on Sleep and Next Day Alertness in People With Obstructive Sleep Apnea

Phase 2
Completed
Conditions
Sleep Apnea, Obstructive
Interventions
First Posted Date
2022-03-31
Last Posted Date
2023-07-06
Lead Sponsor
Flinders University
Target Recruit Count
15
Registration Number
NCT05303935
Locations
🇦🇺

Adelaide Institute for Sleep Health, Adelaide, South Australia, Australia

  • Prev
  • 1
  • 2
  • 3
  • Next

News

Patient-Reported Physical Function Predicts Daratumumab Efficacy in Multiple Myeloma Patients

New research reveals patient-reported physical function serves as a superior prognostic indicator for multiple myeloma treatment outcomes compared to traditional physician assessments.

© Copyright 2025. All Rights Reserved by MedPath